H. Lundbeck A/S

Headache and Migraine Disorders

H. Lundbeck A/S is strongly focused on migraine care, with research spanning chronic migraine, episodic migraine, paediatric migraine, and medication overuse headache. Its studies also address preventive treatment needs in both adults and younger populations.

  • Chronic migraine
  • Episodic migraine
  • Paediatric migraine
  • Medication overuse headache

The sponsor’s clinical portfolio includes interest in reducing migraine frequency and supporting long-term management across age groups.

Endocrine and Hormonal Disorders

The company is active in endocrine disease research, including Cushing’s disease and congenital adrenal hyperplasia. These programmes reflect a therapeutic interest in conditions involving abnormal hormone regulation and adrenal function.

  • Cushing’s disease
  • Congenital adrenal hyperplasia

Its work in this area also connects with broader investigation of disorders linked to cortisol imbalance.

Ophthalmology and Thyroid Eye Disease

H. Lundbeck A/S is involved in research on thyroid eye disease, including moderate-to-severe TED and associated proptosis. This places a clear emphasis on inflammatory eye disease and its impact on orbital symptoms.

  • Thyroid eye disease
  • Moderate-to-severe TED
  • Proptosis

The sponsor’s activity in this field highlights interest in conditions affecting vision, eye appearance, and ocular discomfort.

Neurological and Sleep Disorders

The sponsor also supports research in neurology and sleep medicine, with studies in multiple system atrophy, Parkinson’s disease, and narcolepsy. These programmes reflect attention to progressive neurodegenerative disease and disorders of wakefulness.

  • Multiple system atrophy
  • Parkinson’s disease
  • Narcolepsy

Its research in this area covers both movement-related neurological conditions and central disorders of sleep regulation.

Pain and Sensory Symptom Management

H. Lundbeck A/S includes pain research within its clinical portfolio, indicating interest in symptom relief and sensory symptom control across neurological and headache-related conditions.

  • Pain

This area complements its broader work in headache medicine and other disorders with significant symptom burden.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Portugal Spain
  • Study of Eptinezumab Given Intravenously for Prevention of Chronic Migraine in Adolescents Aged 12-17 Years

    Recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Poland Portugal Spain
  • Study of Lu AG13909 in Adults with Cushing’s Disease to Evaluate Safety and Effectiveness

    Recruiting

    2 1 1
    Investigated drugs:
    France Hungary Italy Poland Romania Spain
  • Study of Amlenetug for Patients with Multiple System Atrophy

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    France Germany Italy Poland Spain
  • Study on Lu AG09222 for Preventing Migraines in Adults Unresponsive to Previous Treatments

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Denmark France Germany Hungary +5
  • Study of Lu AG22515 for Adults with Moderate-to-Severe Thyroid Eye Disease

    Not recruiting

    1 1 1
    Bulgaria Germany Poland Spain